Floatz logo

Vinorelbine

Castration-Resistant Prostate Carcinoma

Beth Israel Deaconess Medical CenterPhase 2Dormant
B
58/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
73/ 100

Competitive context

59 Active assets in the Castration-Resistant Prostate Carcinoma cohort.

Asset / SponsorPhaseRating
Enzalutamide
Prostate Cancer Clinical Trials Consortium
Phase 4BBB
PREDNISONE TABLETS
Janssen Research & Development, LLC
Phase 4BB
Psma-Hbed-Cc
Fred Hutchinson Cancer Center
Phase 3BB
Cyclophosphamide
Zhejiang University
Phase 2BB
Abiraterone Acetate
Alliance for Clinical Trials in Oncology
Phase 4BB

View all 50 →

Same molecule, other indications

Vinorelbine is also rated in:

HER2 positive breast carcinomaDormant
BBB
Indicative ·
74 / 100
View asset →
Recurrent Breast CarcinomaDormant
BBB
Indicative ·
72 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →